Tom Wilemon

November 7, 2019

Grant bolsters Weiss’ pediatric thyroid cancer research

Vivian Weiss, MD, PhD, has been named a 2020 V Scholar and will receive $200,000 from the V Foundation for Cancer Research.

By Tom Wilemon
November 6, 2019

Rathmell receives 2019 Eugene P. Schonfeld Award

The Kidney Cancer Association is recognizing the research accomplishments and leadership achievements of W. Kimryn Rathmell, MD, PhD, with its top honor, the Eugene P. Schonfeld Award.

By Tom Wilemon
October 31, 2019

Rathmell lands award from Lupus Research Alliance

Jeffrey Rathmell, PhD, is a 2019 recipient of the Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity.

By Tom Wilemon
yogurt
October 28, 2019

High fiber, yogurt diet associated with lower lung cancer risk

A diet high in fiber and yogurt is associated with a reduced risk for lung cancer, according to a study by Vanderbilt University Medical Center researchers.

By Tom Wilemon
October 24, 2019

Research summit to highlight genitourinary cancer advances

Some of the nation’s leading genitourinary cancer physicians will speak about the latest advances in care at an OncLive State of the Science Summit held in collaboration with Vanderbilt-Ingram Cancer Center.

By Tom Wilemon
October 24, 2019

Pietenpol, Wilson land Komen cancer research support

Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.

By Tom Wilemon
October 17, 2019

Study finds men have higher mortality rate after breast cancer diagnosis

A new study shows men with breast cancer are more likely to die than their female counterparts, across all stages of disease.
By Tom Wilemon
October 3, 2019

VICC’s Rathmell honored with Louisa Nelson Award

Kimryn Rathmell, MD, PhD, director of the Division of Hematology and Oncology, received an award that honors women who embody the achievement, vision and inspiration of the founder of a local distillery.
By Tom Wilemon
September 25, 2019

Study identifies targeted therapy’s cardiac risks

After a recent study showed that chronic lymphocytic leukemia patients who received ibrutinib as a frontline treatment had a 7% death rate, a new study offers a clearer picture on the reasons for the deaths.
By Tom Wilemon
September 18, 2019

Jackson named to new VICC advanced practice role

Heather Jackson, MSN, RN, APRN, has been promoted to administrative director of Advanced Practice for Vanderbilt-Ingram Cancer Center.
By Tom Wilemon
September 5, 2019

Study backs genetic testing for all metastatic breast cancer patients

By Tom Wilemon
September 4, 2019

Fashion event to help support ovarian cancer research

Vanderbilt Health physicians will be among the runway models during the 7th Annual T.J. Martell Foundation Chic Awearness on Sept. 23.
By Tom Wilemon
1 … 22 23 24 25 26 … 39